drugset / Trial / NCT00130338
Rivastigmine Capsules in Patients With Probable Vascular Dementia
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The goal of this research study is to evaluate, in the open-label extension phase, the effectiveness, tolerability and safety of rivastigmine capsules in males and females between the ages of 50 and 85 years old with probable vascular dementia.
Timeline
- Start
- 2002-02
- Primary completion
- 2006-05
- Completion
- 2006-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivastigmine | Small molecule | — | — |